Insights into the mechanism and pharmacology of neurotransmitter sodium symporters.

Neurotransmitter sodium symporters (NSS) belong to the SLC6 family of solute carriers and play an essential role in neurotransmitter homeostasis throughout the body. In the past decade, structural studies employing bacterial orthologs of NSSs have provided insight into the mechanism of neurotransmitter transport. While the overall architecture of SLC6 transporters is conserved among species, in comparison to the bacterial homologs, the eukaryotic SLC6 family members harbor differences in amino acid sequence and molecular structure, which underpins their functional and pharmacological diversity, as well as their ligand specificity. Here, we review the structures and mechanisms of eukaryotic NSSs, focusing on the molecular basis for ligand recognition and on transport mechanism.

• Publication year

  2019

• Venue

  Current Opinion in Structural Biology

• Publication date

  2019-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.sbi.2019.03.011PMID 30921707PMCID PMC6592764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Computation-guided analysis of paroxetine binding to hSERT reveals functionally important structural elements and dynamics.

  2019cited by this paper
• Substrate-modulated unwinding of transmembrane helices in the NSS transporter LeuT

  2018cited by this paper
• Cholesterol binding to a conserved site modulates the conformation, pharmacology, and transport kinetics of the human serotonin transporter

  2018cited by this paper
• Thermostabilization and purification of the human dopamine transporter (hDAT) in an inhibitor and allosteric ligand bound conformation

  2018cited by this paper
• How structural elements evolving from bacterial to human SLC6 transporters enabled new functional properties

  2018cited by this paper
• A direct interaction of cholesterol with the dopamine transporter prevents its out-to-inward transition

  2018cited by this paper
• Mapping the Binding Site for Escitalopram and Paroxetine in the Human Serotonin Transporter Using Genetically Encoded Photo-Cross-Linkers.

  2017cited by this paper
• Conformational dynamics of a neurotransmitter:sodium symporter in a lipid bilayer

  2017cited by this paper
• The N Terminus Specifies the Switch between Transport Modes of the Human Serotonin Transporter*

  2017cited by this paper
• Scaffold Repurposing of Nucleosides (Adenosine Receptor Agonists): Enhanced Activity at the Human Dopamine and Norepinephrine Sodium Symporters.

  2017cited by this paper
• The role of transmembrane segment 5 (TM5) in Na2 release and the conformational transition of neurotransmitter:sodium symporters toward the inward-open state

  2017cited by this paper
• Structural basis for recognition of diverse antidepressants by the human serotonin transporter

  2017cited by this paper
• Structural biology of solute carrier (SLC) membrane transport proteins

  2017cited by this paper
• Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters

  2016cited by this paper
• Mechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter

  2016cited by this paper
• A conserved leucine occupies the empty substrate site of LeuT in the Na+-free return state

  2016cited by this paper
• X-ray structures and mechanism of the human serotonin transporter

  2016cited by this paper
• Shared Molecular Mechanisms of Membrane Transporters.

  2016cited by this paper
• Studies of the Biogenic Amine Transporters 15. Identification of Novel Allosteric Dopamine Transporter Ligands with Nanomolar Potency

  2015cited by this paper
• Functional mechanisms of neurotransmitter transporters regulated by lipid-protein interactions of their terminal loops.

  2015cited by this paper
• A Salt Bridge Linking the First Intracellular Loop with the C Terminus Facilitates the Folding of the Serotonin Transporter*

  2015cited by this paper
• Monoamine transporters: insights from molecular dynamics simulations

  2015cited by this paper
• X-ray structures of Drosophila dopamine transporter in complex with nisoxetine and reboxetine

  2015cited by this paper
• Dual Action of Zn2+ on the Transport Cycle of the Dopamine Transporter*

  2015cited by this paper
• Two Na+ Sites Control Conformational Change in a Neurotransmitter Transporter Homolog*

  2015cited by this paper
• Neurotransmitter and psychostimulant recognition by the dopamine transporter

  2015cited by this paper
• Structure and Regulatory Interactions of the Cytoplasmic Terminal Domains of Serotonin Transporter

  2014cited by this paper
• The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse

  2014cited by this paper
• A mechanism for intracellular release of Na+ by neurotransmitter/sodium symporters

  2014cited by this paper
• The Second Sodium Site in the Dopamine Transporter Controls Cation Permeation and Is Regulated by Chloride*

  2014cited by this paper
• The SLC6 transporters: perspectives on structure, functions, regulation, and models for transporter dysfunction

  2013cited by this paper
• Amphetamine actions at the serotonin transporter rely on the availability of phosphatidylinositol-4,5-bisphosphate

  2013cited by this paper
• Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder

  2013cited by this paper
• Neurotransmitter transporters: structure meets function.

  2013cited by this paper
• Chloride binding site of neurotransmitter sodium symporters

  2013cited by this paper
• Structural basis for action by diverse antidepressants on biogenic amine transporters

  2013cited by this paper
• X-ray structure of dopamine transporter elucidates antidepressant mechanism

  2013cited by this paper
• Mutational Analysis of the High-Affinity Zinc Binding Site Validates a Refined Human Dopamine Transporter Homology Model

  2013cited by this paper
• Steric Hindrance Mutagenesis in the Conserved Extracellular Vestibule Impedes Allosteric Binding of Antidepressants to the Serotonin Transporter*

  2012cited by this paper
• Interaction of Antidepressants with the Serotonin and Norepinephrine Transporters

  2012cited by this paper
• X-ray structures of LeuT in substrate-free outward-open and apo inward-open states

  2012cited by this paper
• The monoamine neurotransmitter disorders: an expanding range of neurological syndromes.

  2011cited by this paper
• Insights into transport mechanism from LeuT engineered to transport tryptophan

  2011cited by this paper
• Site-Directed Mutations near Transmembrane Domain 1 Alter Conformation and Function of Norepinephrine and Dopamine Transporters

  2011cited by this paper
• SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation

  2011influential reference
• The N Terminus of Monoamine Transporters Is a Lever Required for the Action of Amphetamines*

  2010cited by this paper
• Mutational Mapping and Modeling of the Binding Site for (S)-Citalopram in the Human Serotonin Transporter*

  2009cited by this paper
• Binding of an octylglucoside detergent molecule in the second substrate (S2) site of LeuT establishes an inhibitor-bound conformation

  2009cited by this paper
• Antidepressant specificity of serotonin transporter suggested by three LeuT–SSRI structures

  2009cited by this paper
• Unlocking the molecular secrets of sodium-coupled transporters

  2009cited by this paper
• A Competitive Inhibitor Traps LeuT in an Open-to-Out Conformation

  2008cited by this paper
• Simple transporter trafficking model for amphetamine‐induced dopamine efflux

  2007cited by this paper
• Identification of a chloride ion binding site in Na+/Cl−-dependent transporters

  2007cited by this paper
• Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization

  2005cited by this paper
• Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters

  2005cited by this paper
• Neurotransmitter transporters: recent progress.

  1993cited by this paper
• Simple Allosteric Model for Membrane Pumps

  1966cited by this paper
• A General Theory of Membrane Transport From Studies of Bacteria

  1957cited by this paper

• Molecular basis of human GABA transporter 3 inhibition

  2025cites this paper
• Heterocycle-fused phenylcyclohexylamines as novel multi-target antagonists of N-methyl-D-aspartate (NMDA) receptor and monoamine transporter for treating depression.

  2025cites this paper
• Exploring the Structural Dynamics of LeuT Using EPR Spectroscopy: A Focus on Transmembrane Helix 10

  2025cites this paper
• Dynamic Mechanism of Norepinephrine Reuptake and Antidepressants Blockade Regulated by Membrane Potential.

  2025cites this paper
• Transcriptomics insights into the functional role of tick Ixodes ricinus proteins metalloprotease and antigen p23

  2025cites this paper
• An Orchestrated Interaction Network at the Binding Site of Human SERT Enables the Serotonin Occlusion and Import.

  2025cites this paper
• Unifying perspectives on the activity and genotypic targeting of pharmacological chaperones

  2025cites this paper
• (-)-Syringaresinol Exerts an Antidepressant-like Activity in Mice by Noncompetitive Inhibition of the Serotonin Transporter

  2024cites this paper
• Cryo-EM structure of ACE2-SIT1 in complex with tiagabine

  2024cites this paper
• Dimerization and antidepressant recognition at noradrenaline transporter

  2024cites this paper
• A Conserved Intramolecular Ion-Pair Plays a Critical but Divergent Role in Regulation of Dimerization and Transport Function among the Monoamine Transporters

  2024cites this paper
• Dynamic role of GlyT1 as glycine sink or source: pharmacological implications for the gain control of NMDA receptors

  2024cites this paper
• Functional contribution of the intestinal microbiome in autism spectrum disorder, attention deficit hyperactivity disorder, and Rett syndrome: a systematic review of pediatric and adult studies

  2024cites this paper
• Molecular basis of inhibition of the amino acid transporter B0AT1 (SLC6A19)

  2024cites this paper
• Computational Chemistry in Structure-Based Solute Carrier Transporter Drug Design: Recent Advances and Future Perspectives

  2024cites this paper
• Monoamine transporter ubiquitination and inward-open conformation synergistically maximize transporter endocytosis

  2024cites this paper
• Stereochemical optimization of N,2-substituted cycloalkylamines as norepinephrine reuptake inhibitors.

  2024cites this paper
• Balancing Therapeutic Efficacy and Safety of MDMA and Novel MDXX Analogues as Novel Treatments for Autism Spectrum Disorder

  2023cites this paper
• SLC6A1 variant pathogenicity, molecular function and phenotype: a genetic and clinical analysis

  2023influential citation
• Structures and membrane interactions of native serotonin transporter in complexes with psychostimulants

  2023cites this paper
• Molecular basis for substrate recognition and transport of human GABA transporter GAT1

  2023cites this paper
• Unique Substrate Recognition and Sodium–Substrate Binding Stoichiometry in a Bacterial Serotonin Transporter, TuriSERT

  2023cites this paper
• Structural insight into the substrate recognition and transport mechanism of amino acid transporter complex ACE2-B0AT1 and ACE2-SIT1

  2023cites this paper
• Applications and Potential of In Silico Approaches for Psychedelic Chemistry

  2023cites this paper
• Understanding Mechanisms of Secondary Active Transport by Analyzing the Effects of Mutations and Stoichiometry.

  2022cites this paper
• Cell-Free Expression to Probe Co-Translational Insertion of an Alpha Helical Membrane Protein

  2022cites this paper
• Theoretical study of active secondary transport: Unexpected differences in molecular mechanisms for antiporters and symporters.

  2022cites this paper
• Molecular characterization of the serotonergic transporter from the cestode Echinococcus granulosus: pharmacology and potential role in the nervous system

  2022cites this paper
• Two Lignan Glycosides from Albizia julibrissin Durazz. Noncompetitively Inhibit Serotonin Transporter

  2022cites this paper
• Recent advances on the inhibition of human solute carriers: Therapeutic implications and mechanistic insights.

  2022cites this paper
• Allosteric Binding of MDMA to the Human Serotonin Transporter (hSERT) via Ensemble Binding Space Analysis with ΔG Calculations, Induced Fit Docking and Monte Carlo Simulations

  2022cites this paper
• A structure and evolutionary-based classification of solute carriers

  2022cites this paper
• Structural Pharmacology of Cation-Chloride Cotransporters

  2022cites this paper
• Paroxetine—Overview of the Molecular Mechanisms of Action

  2021cites this paper
• Glycine Transporter 2: Mechanism and Allosteric Modulation

  2021cites this paper
• Molecular Mechanisms of Active Transport in Antiporters: Kinetic Constraints and Efficiency.

  2021cites this paper
• Induced fit, ensemble binding space docking and Monte Carlo simulations of MDMA ‘ecstasy’ and 3D pharmacophore design of MDMA derivatives on the human serotonin transporter (hSERT)

  2021cites this paper
• Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding

  2021cites this paper
• Understanding the Polypharmacological Profiles of Triple Reuptake Inhibitors by Molecular Simulation.

  2021cites this paper
• Label-free high-throughput screening assay for the identification of norepinephrine transporter (NET/SLC6A2) inhibitors

  2021cites this paper
• Reconstitution of GABA, Glycine and Glutamate Transporters

  2021cites this paper
• Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro

  2021cites this paper
• Direct coupling of oligomerization and oligomerization-driven endocytosis of the dopamine transporter to its conformational mechanics and activity

  2021cites this paper
• Chemical and structural investigation of the paroxetine-human serotonin transporter complex

  2020cites this paper
• Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.

  2020cites this paper
• Toward a Systematic Structural and Functional Annotation of Solute Carriers Transporters—Example of the SLC6 and SLC7 Families

  2020influential citation
• Membrane Physiology and Biophysics—What Remains to Be Done?

  2020cites this paper
• Studies of structural determinants of substrate binding in the Creatine Transporter (CreaT, SLC6A8) using molecular models

  2020cites this paper
• Case-Control Study of the Effects of Gut Microbiota Composition on Neurotransmitter Metabolic Pathways in Children With Attention Deficit Hyperactivity Disorder

  2020cites this paper
• Editorial overview: Synapses: bridging the gap between their structure and function.

  2019cites this paper
• General principles of secondary active transporter function.

  2019cites this paper
• Computational Dissection of Membrane Transport at a Microscopic Level.

  2019cites this paper
• Structure and Gating Dynamics of Na+/Cl– Coupled Neurotransmitter Transporters

  2019cites this paper
• Tales of tails in transporters

  2019cites this paper
• Decoding homodimerization and antidepressant recognition at the norepinephrine 1 transporter 2

  year unknowncites this paper